Maxalt Smelt (Rizatriptan Benzoate)

Rizatriptan works by selectively activating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve fibers. This activation causes vasoconstriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, interrupting the migraine pain pathway.

The exact dose of Maxalt Smelt is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of rizatriptan in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Maxalt Smelt. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both rizatriptan and sumatriptan belong to the triptan class and act on the same serotonin receptors. Rizatriptan generally has a slightly longer half‑life, which may provide extended relief for some patients, while sumatriptan often has a faster onset. Choice between them depends on individual response, tolerability, and physician preference.

Store Maxalt Smelt at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect it from excess moisture, direct sunlight, and extreme heat. Keep the medication out of reach of children and do not use it after the expiration date.

Maxalt Smelt is taken orally, usually as a single tablet at the first sign of a migraine attack. It should be swallowed whole with a glass of water and not chewed or crushed. If the migraine persists, a second dose may be taken after a minimum interval, as directed by the prescriber.

Serious risks include chest pain or tightness, which may indicate coronary vasospasm, and serotonin syndrome, a potentially life‑threatening condition that can occur when combined with other serotonergic drugs. Severe allergic reactions such as anaphylaxis are also possible, requiring immediate medical attention.

Patients with a history of uncontrolled hypertension, coronary artery disease, cerebrovascular disease, peripheral vascular disease, or significant cardiac arrhythmias should avoid rizatriptan. It is also contraindicated in individuals who have used other triptans, ergotamine derivatives, or MAO inhibitors within the past 24 hours.